TNF Pharmaceuticals Inc. (TNFA) Stock Price

0.1232 ▼ -0.0068 (-5.23%)
Open: 0.125 Vol: 0 Day's range: 0.119 - 0.1268 Jun 30, 15:49 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
TNFA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY NEUTRAL NEUTRAL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.12▼ 0.12▲ 0.12▲ 0.13▼ 0.14▼
MA10 0.12▲ 0.12▲ 0.12▲ 0.14▼ 0.16▼
MA20 0.12▲ 0.12▲ 0.12▲ 0.15▼ 0.25▼
MA50 0.12▲ 0.13▼ 0.13▼ 0.17▼ N/A    
MA100 0.13▼ 0.13▼ 0.15▼ 0.29▼ N/A    
MA200 0.13▼ 0.15▼ 0.16▼ 0.81▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.001▲ 0.001▲ 0.001▲ 0.000▼ 0.035▲
RSI 50.773▲ 47.539▼ 45.572▼ 33.151▼ 23.108▼
STOCH 70.045     26.371     30.839     22.525     4.976▼
WILL %R -48.649     -62.162     -46.309     -96.218▼ -97.508▼
CCI 57.422     31.490     64.584     -100.241▼ -118.840▼
Latest Filters Detected On TNFA
▼ MACD $TNFA MACD(12,26,9) Crossed Below Signal Line Set Alert
▼ GAP $TNFA Open Gap Down %3 Set Alert
▼ GAP $TNFA Open Gap Down %2 Set Alert
TNF Pharmaceuticals Inc. News
TNF Pharmaceuticals, Inc. (TNFA) - Yahoo Finance
Friday, June 27, 2025 12:53 PM
TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development. BALTIMORE, April 22, 2025--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNF" or the "Company"), a clinical stage ...
TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease
Tuesday, June 24, 2025 06:15 AM
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, today ...
TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease - Business Wire
Tuesday, June 24, 2025 02:15 AM
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing two novel therapeutic platforms that treat the ...
TNFA historical stock data
date open high low close volume
30/06/25 0.125 0.1268 0.119 0.1232 2,763,605
27/06/25 0.124 0.133 0.115 0.13 5,220,300
26/06/25 0.13 0.1355 0.1211 0.1255 3,687,882
25/06/25 0.1371 0.1552 0.1252 0.1376 7,609,645
24/06/25 0.1339 0.1435 0.1255 0.1398 1,952,045
23/06/25 0.135 0.147 0.132 0.138 3,658,400
20/06/25 0.1353 0.1477 0.1353 0.1395 1,374,724
18/06/25 0.131 0.147 0.131 0.14 1,821,200
17/06/25 0.144 0.154 0.142 0.15 1,736,800
16/06/25 0.139 0.149 0.131 0.146 1,474,400
Quote Details
52wk Low:0.115
52wk High:2.16
Vol:0
Avg Vol(3m):86.3M
1Y Chng:+0.00%
1M Chng:-34.78%
Add to Watch List
More Information
Index US Composite
Market Cap. 1.94M